For further information, refer to the Safety Data Sheet (SDS)
8:a028936
BPC-157 acetate compound record
View Study [5]"The Potential of the Peptide Drug Semax and Its Derivative for Correcting Pathological Impairments in the Animal Model of Alzheimer's Disease" Radchenko AI, Kuzubova EV, Apostol AA, 2025 Finding: In mice modeling Alzheimer's disease, both Semax and its derivatives improved cognitive function on multiple tests (open field, object recognition, maze navigation) and reduced amyloid plaque buildup in the brain
In the present study, absolute bioavailability of diosgenin, charantin, and hydroxychalcone was found to be 9, 8.18, and 10.54%, respectively
Our expert team will help you create a personalized treatment plan